Clinical Study

AUSTIN, Texas, July 22, 2026 Natera announced the publication of a prospective, multicenter study in JAMA Dermatology demonstrating that...

NASHVILLE, Tenn., July 20, 2026 Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America,...

GENEVA, Switzerland, July 9, 2026 MindMaze Therapeutics Holding SA has announced its support for a University of Pittsburgh clinical...

MAPLE GROVE, Minn., July 7, 2026 Francis Medical has announced that Orange County Urology Associates (OCUA) has become the...

BEVERLY, Mass., July 7, 2026 Akston Biosciences Corporation has announced encouraging preclinical data demonstrating that its investigational NGF-targeting Ambifect®...

ALAMEDA, Calif., July 7, 2026 Penumbra, Inc., a global leader in thrombectomy technologies, has announced the first patient enrollment...

AARHUS, Denmark, June 17, 2026 NMD Pharma A/S announced new positive clinical findings from its Phase 2a SYNAPSE-CMT study...

NEW YORK, June 16, 2026 Intelligent Bio Solutions (INBS) announced the initiation of a critical clinical Interference Study designed...

BRIDGEWATER, N.J., June 5, 2026 Amneal Pharmaceuticals announced positive interim results from the ongoing Phase 4 ELEVATE-PD study, demonstrating...

SUNNYVALE, Calif., May 13, 2026 Cepheid, a Danaher company, announced that it has received CE marking under the European...